Chargement en cours...
In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models
We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae, streptococci, enterococci, and Haemophilus influenzae with those of various macrolides and pristinamycin. Unlike...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2001
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC90532/ https://ncbi.nlm.nih.gov/pubmed/11353612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.6.1688-1692.2001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|